Frequently asked questions
Is Dianthus Therapeutics (DNTH) stock halal to invest in?
As of , DNTH is not Shariah-compliant and therefore
considered halal to invest in. This assessment is based on the data available in
Dianthus Therapeutics's most recent financial reports.
As of , DNTH is not Shariah-compliant and therefore
not considered halal to invest in. This assessment is based on the data available in
Dianthus Therapeutics's most recent financial reports.
As of , DNTH is flagged as not Shariah-compliant in
terms of Shariah compliance based on the company's latest financial reports. This
means that while the company's operations do not definitively violate Islamic guidelines, there are
certain aspects of Dianthus Therapeutics's business that require careful consideration.
Does Dianthus Therapeutics have any interest income?
Yes, Dianthus Therapeutics does have interest income. According to the company's latest annual report for
the fiscal year ending Dec 31, 2023, Dianthus Therapeutics reported revenue of
2826000 and interest income of
4764000. The interest income represents
62.77% of the combined total. It's worth noting that some companies
may report additional interest income as part of their revenue. For a detailed breakdown of all interest
income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
No, Dianthus Therapeutics has not reported any interest income. According to the company's latest annual
report for the fiscal year ending Dec 31, 2023, Dianthus Therapeutics reported total revenue
of 2826000, with no separate interest income disclosed. However,
it's worth noting that some companies may report interest income as part of their revenue. For a detailed
breakdown of all interest income and revenue segments, please refer to the full Shariah compliance
report available in the Zoya app.
What guidelines are used to determine if Dianthus Therapeutics stock is Shariah-compliant?
We use the guidelines set by the Accounting and Auditing Organization for Islamic Financial Institutions
(AAOIFI) to assess Shariah compliance. AAOIFI is a leading international organization that establishes
standards for Islamic finance. Their guidelines help determine if a company's business activities and
financial structure align with Islamic principles. These standards are widely respected in the Islamic
finance industry and provide a consistent framework for evaluating the Shariah compliance of stocks and
other financial instruments. AAOIFI's Shariah board includes renowned scholars such as Sheikh Muhammad
Taqi Usmani, Sheikh Mohamed Ali Elgari, Sheikh Abdullah AlManea, Sheikh Nizam Yaquby, and Dr. Aznan Hassan.
How often is Dianthus Therapeutics stock reviewed for Shariah compliance?
The Shariah compliance status of Dianthus Therapeutics stock is reviewed on a regular basis, with a minimum
frequency of once per quarter. However, if there are any significant changes or major developments
in the company's operations that may impact its compliance, an immediate review will be conducted to
ensure ongoing adherence to Shariah principles.
How can I stay updated on Dianthus Therapeutics's compliance status?
To stay informed, we recommend regularly checking Zoya for updates. You can also enable alerts within
the Zoya app to receive notifications whenever there is a change in the Shariah compliance of DNTH,
or any other stocks you are monitoring. This is particularly useful as Shariah compliance can fluctuate
due to changes in a company's financial ratios or business activities.
Are dividends from Dianthus Therapeutics stock considered halal?
Yes, dividends from DNTH are considered halal. However, you may need to purify a portion of the
dividend if the company has any impermissible revenue. Shariah standards typically allow up to 5% of
revenue from impermissible sources for a stock to remain compliant. To find the exact percentage of
impermissible revenue for Dianthus Therapeutics (DNTH), check the Zoya app. For more details on the
purification process, read
our comprehensive guide.
No, dividends from DNTH are not considered halal because the stock is currently not
Shariah-compliant. When a stock is non-compliant, any dividends received from it are considered
impermissible income and should be donated to charity as a form of purification. To learn more about
the purification process and how to handle impermissible income, read
our comprehensive guide.
Do I need to pay Zakat on my Dianthus Therapeutics shares?
If you hold Dianthus Therapeutics stock as an investment, through an Employee Stock Ownership
Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and
meet the Nisab threshold, you may be required to pay Zakat on it. The calculation of Zakat on investments
can be complex and depends on various factors. To help make this easy, we've created a free
Zakat calculator for stocks. For a more
seamless experience, use the
Zoya mobile app, where you can link your brokerage account to
automatically import holdings.
